These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16566454)

  • 1. Animal-free culture process for manufacture of viral vaccines: process validation and regulatory perspectives.
    Pierard I; Mareschal JC; Gonze MM; Duchêne M
    Dev Biol (Basel); 2006; 123():283-90; discussion 291-308. PubMed ID: 16566454
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control of bovine serum used for vaccine production.
    Mareschal JC
    Dev Biol Stand; 1999; 99():61-8. PubMed ID: 10404877
    [No Abstract]   [Full Text] [Related]  

  • 3. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why do we still use serum in the production of biopharmaceuticals?
    Shah G
    Dev Biol Stand; 1999; 99():17-22. PubMed ID: 10404871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summary and conclusion. Animal sera, animal sera derivatives and substitutes used in the manufacture of pharmaceuticals.
    Castle P; Robertson JS
    Dev Biol Stand; 1999; 99():191-6. PubMed ID: 10404890
    [No Abstract]   [Full Text] [Related]  

  • 6. Validation of cell culture media components.
    Stacey G
    Hum Fertil (Camb); 2004 Jun; 7(2):113-8. PubMed ID: 15223760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elimination of serum from cell culture medium.
    Lubiniecki AS
    Dev Biol Stand; 1999; 99():153-6. PubMed ID: 10404886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility: Respect your cells!
    Baker M
    Nature; 2016 Sep; 537(7620):433-5. PubMed ID: 27629646
    [No Abstract]   [Full Text] [Related]  

  • 9. Bovine polyomavirus, a frequent contaminant of calf sera.
    van der Noordaa J; Sol CJ; Schuurman R
    Dev Biol Stand; 1999; 99():45-7. PubMed ID: 10404875
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine cell substrates: bovine and porcine virus considerations.
    Wessman SJ
    Dev Biol (Basel); 2006; 123():273-80; discussion 291-308. PubMed ID: 16566453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for oncogenic properties of heteroploidy cell lines.
    Sanford KK
    Natl Cancer Inst Monogr; 1968 Dec; 29():283-7. PubMed ID: 5720798
    [No Abstract]   [Full Text] [Related]  

  • 12. Bovine serum: reducing the variables through the use of donor herds.
    Rolleston WB
    Dev Biol Stand; 1999; 99():79-86. PubMed ID: 10404879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feeder-free culture of human embryonic stem cells.
    Amit M; Itskovitz-Eldor J
    Methods Enzymol; 2006; 420():37-49. PubMed ID: 17161692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adventitious agent test methods.
    Sheets RL
    Dev Biol (Basel); 2006; 123():135-45; discussion 183-97. PubMed ID: 16566441
    [No Abstract]   [Full Text] [Related]  

  • 15. Basis for sample size in international conference on harmonization guidances.
    Lubiniecki A
    Dev Biol (Basel); 2006; 123():201-5; discussion 217-22. PubMed ID: 16566446
    [No Abstract]   [Full Text] [Related]  

  • 16. Detecting viruses in sera: methods used and their merits.
    Jennings A
    Dev Biol Stand; 1999; 99():51-9. PubMed ID: 10404876
    [No Abstract]   [Full Text] [Related]  

  • 17. An overview of animal cell substrates for biological products.
    Petricciani J; Sheets R
    Biologicals; 2008 Nov; 36(6):359-62. PubMed ID: 18674929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell substrates: lessons learned and challenges remaining.
    Petricciani JC
    Dev Biol Stand; 1999; 100():57-63. PubMed ID: 10616176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of cell culture systems: viral flora of tissue sources and tissue and medium antigens in vaccines--summary.
    Sigel MM; von Magnus H
    Natl Cancer Inst Monogr; 1968 Dec; 29():551-4. PubMed ID: 4976867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.